EUVIMEDObjevte EUVIMED
Open access

Affordable GLP-1? When Digital Platforms Meet Policy Reform

Xiangming Jenny Zhan

Journal of Medical Internet Research · 2026-06-01 · 28 · e102069-e102069

DOI: 10.2196/102069 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2026-06-01. Written by Xiangming Jenny Zhan. Major MEDLINE topics: Glucagon-Like Peptide 1, Health Policy. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Recent shifts in US policy and digital platforms are making obesity medications more affordable. In this News and Perspectives article, JMIR Correspondent Xiangming Jenny Zhan reports on this emerging access model and its potential implications.

Subjects

MeSH terms (MEDLINE)

Glucagon-Like Peptide 1Health PolicyHumansUnited StatesDigital MediaDigital HealthObesity

Author keywords

chronic diseasedrug costsglucagon-like peptide-1 receptor agonistshealth services accessibilityinsurance, healthmedication adherencetelemedicine

Substances

Glucagon-Like Peptide 1

Cite

APA

Zhan, X. J. (2026). Affordable GLP-1? When Digital Platforms Meet Policy Reform. Journal of Medical Internet Research, 28, e102069-e102069. https://doi.org/10.2196/102069

Vancouver

Zhan XJ. Affordable GLP-1? When Digital Platforms Meet Policy Reform. Journal of Medical Internet Research. 2026;28:e102069-e102069. doi:10.2196/102069

BibTeX
@article{Zhan2026,
  author = {Zhan, Xiangming Jenny},
  title = {Affordable GLP-1? When Digital Platforms Meet Policy Reform},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e102069--e102069},
  doi = {10.2196/102069}
}
Start for free →